Given full information about the risks of long-term opioid therapy, patients often see the value of exploring other options rather than thinking their physicians are reluctant to prescribe narcotics for fear of litigation or regulatory action.
AMA J Ethics. 2015;17(3):202-208. doi:
10.1001/journalofethics.2015.17.3.ecas1-1503.
Amy D. Hendrix-Dicken joins Ethics Talk to discuss her article, coauthored with Drs Sarah J. Passmore, Michael A. Baxter, and Lauren K. Conway: “McGirt v Oklahoma and What Clinicians Should Know About Present-Day Child Abuse and Legacies of Forced Migration.”
Dr Evan Anderson joins Ethics Talk to discuss his article, coauthored with Professor Scott Burris: “Which Skills Are Key to Public Health Leaders’ Success in Crisis Management?”
Turfing is a colloquialism that refers to what clinicians do to patients whose needs do not fit neatly and tidily into typical clinical placement protocols.
AMA J Ethics. 2023;25(12):E885-891. doi:
10.1001/amajethics.2023.885.
The drug Neurontin is used as an example of why it is permissible for physicians to engage in off-label prescribing, but off-label marketing by pharmaceutical companies is prohibited by the FDA.